Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1994 Aug;55(2):278–286.

Nature and Recurrence of AVPR2 Mutations in X-linked Nephrogenic Diabetes Insipidus

Daniel G Bichet, Mariel Birnbaumer, Michèle Lonergan, Marie-Françoise Arthus, Walter Rosenthal, Paul Goodyer, Hubert Nivet, Stéphane Benoit, Philip Giampietro, Simonetta Simonetti, Alfred Fish, Chester B Whitley, Philippe Jaeger, Joseph Gertner, Maria New, Francis J DiBona, Bernard S Kaplan, Gary L Robertson, Geoffrey N Hendy, T Mary Fujiwara, Kenneth Morgan
PMCID: PMC1918376  PMID: 8037205

Abstract

X-linked nephrogenic diabetes insipidus (NDI) is a rare disease with defective renal and extrarenal arginine-vasopressin V2 receptor responses due to mutations in the AVPR2 gene in Xq28. We analyzed 31 independent NDI families to determine the nature and recurrence of AVPR2 mutations. Twenty-one new putative disease-causing mutations were identified: 113delCT, 253del35, 255del9, 274insG, V88M, R106C, 402delCT, C112R, Y124X, S126F, W164S, S167L, 684delTA, 804insG, W284X, A285P, W293X, R337X, and three large deletions or gene rearrangements. Five other mutations—R113W, Y128S, R137H, R181C, and R202C—that previously had been reported in other families were detected. There was evidence for recurrent mutation for four mutations (R113W, R137H, S167L, and R337X). Eight de novo mutation events were detected (274insG, R106C, Y128S, 167L [twice], R202C, 684delTA, and R337X). The origins were maternal (one), grandmaternal (one), and grandpaternal (six). In the 31 NDI families and 6 families previously reported by us, there is evidence both for mutation hot spots for nucleotide substitutions and for small deletions and insertions. More than half (58%) of the nucleotide substitutions in 26 families could be a consequence of 5-methylcytosine deamination at a CpG dinucleotide. Most of the small deletions and insertions could be attributed to slipped mispairing during DNA replication.

Full text

PDF
278

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bichet D. G., Arthus M. F., Lonergan M., Hendy G. N., Paradis A. J., Fujiwara T. M., Morgan K., Gregory M. C., Rosenthal W., Didwania A. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest. 1993 Sep;92(3):1262–1268. doi: 10.1172/JCI116698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bichet D. G., Hendy G. N., Lonergan M., Arthus M. F., Ligier S., Pausova Z., Kluge R., Zingg H., Saenger P., Oppenheimer E. X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies. Am J Hum Genet. 1992 Nov;51(5):1089–1102. [PMC free article] [PubMed] [Google Scholar]
  3. Bichet D. G., Razi M., Lonergan M., Arthus M. F., Papukna V., Kortas C., Barjon J. N. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med. 1988 Apr 7;318(14):881–887. doi: 10.1056/NEJM198804073181403. [DOI] [PubMed] [Google Scholar]
  4. Birnbaumer M., Seibold A., Gilbert S., Ishido M., Barberis C., Antaramian A., Brabet P., Rosenthal W. Molecular cloning of the receptor for human antidiuretic hormone. Nature. 1992 May 28;357(6376):333–335. doi: 10.1038/357333a0. [DOI] [PubMed] [Google Scholar]
  5. Chakravarti A. Fragile X founder effect? Nat Genet. 1992 Jul;1(4):237–238. doi: 10.1038/ng0792-237. [DOI] [PubMed] [Google Scholar]
  6. Cooper D. N., Krawczak M. The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet. 1990 Jun;85(1):55–74. doi: 10.1007/BF00276326. [DOI] [PubMed] [Google Scholar]
  7. Eng C. M., Resnick-Silverman L. A., Niehaus D. J., Astrin K. H., Desnick R. J. Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease. Am J Hum Genet. 1993 Dec;53(6):1186–1197. [PMC free article] [PubMed] [Google Scholar]
  8. Filosa S., Calabrò V., Lania G., Vulliamy T. J., Brancati C., Tagarelli A., Luzzatto L., Martini G. G6PD haplotypes spanning Xq28 from F8C to red/green color vision. Genomics. 1993 Jul;17(1):6–14. doi: 10.1006/geno.1993.1276. [DOI] [PubMed] [Google Scholar]
  9. Holtzman E. J., Harris H. W., Jr, Kolakowski L. F., Jr, Guay-Woodford L. M., Botelho B., Ausiello D. A. Brief report: a molecular defect in the vasopressin V2-receptor gene causing nephrogenic diabetes insipidus. N Engl J Med. 1993 May 27;328(21):1534–1537. doi: 10.1056/NEJM199305273282105. [DOI] [PubMed] [Google Scholar]
  10. Holtzman E. J., Kolakowski L. F., Jr, O'Brien D., Crawford J. D., Ausiello D. A. A Null mutation in the vasopressin V2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus in the Hopewell kindred. Hum Mol Genet. 1993 Aug;2(8):1201–1204. doi: 10.1093/hmg/2.8.1201. [DOI] [PubMed] [Google Scholar]
  11. Jeanpierre M. Germinal mosaicism and risk calculation in X-linked diseases. Am J Hum Genet. 1992 May;50(5):960–967. [PMC free article] [PubMed] [Google Scholar]
  12. Krawczak M., Cooper D. N. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet. 1991 Mar;86(5):425–441. doi: 10.1007/BF00194629. [DOI] [PubMed] [Google Scholar]
  13. Merendino J. J., Jr, Speigel A. M., Crawford J. D., O'Carroll A. M., Brownstein M. J., Lolait S. J. Brief report: a mutation in the vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus. N Engl J Med. 1993 May 27;328(21):1538–1541. doi: 10.1056/NEJM199305273282106. [DOI] [PubMed] [Google Scholar]
  14. Pan Y., Metzenberg A., Das S., Jing B., Gitschier J. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet. 1992 Oct;2(2):103–106. doi: 10.1038/ng1092-103. [DOI] [PubMed] [Google Scholar]
  15. Rosenthal W., Antaramian A., Gilbert S., Birnbaumer M. Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. J Biol Chem. 1993 Jun 25;268(18):13030–13033. [PubMed] [Google Scholar]
  16. Rosenthal W., Seibold A., Antaramian A., Lonergan M., Arthus M. F., Hendy G. N., Birnbaumer M., Bichet D. G. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature. 1992 Sep 17;359(6392):233–235. doi: 10.1038/359233a0. [DOI] [PubMed] [Google Scholar]
  17. Schlessinger D., Mandel J. L., Monaco A. P., Nelson D. L., Willard H. F. Report and abstracts of the Fourth International Workshop on Human X Chromosome Mapping 1993. St. Louis, Missouri, May 9-12, 1993. Cytogenet Cell Genet. 1993;64(3-4):147–194. doi: 10.1159/000133572. [DOI] [PubMed] [Google Scholar]
  18. Seibold A., Brabet P., Rosenthal W., Birnbaumer M. Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet. 1992 Nov;51(5):1078–1083. [PMC free article] [PubMed] [Google Scholar]
  19. Sinden R. R., Wells R. D. DNA structure, mutations, and human genetic disease. Curr Opin Biotechnol. 1992 Dec;3(6):612–622. doi: 10.1016/0958-1669(92)90005-4. [DOI] [PubMed] [Google Scholar]
  20. Tsukaguchi H., Matsubara H., Aritaki S., Kimura T., Abe S., Inada M. Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Biochem Biophys Res Commun. 1993 Dec 15;197(2):1000–1010. doi: 10.1006/bbrc.1993.2578. [DOI] [PubMed] [Google Scholar]
  21. van den Ouweland A. M., Dreesen J. C., Verdijk M., Knoers N. V., Monnens L. A., Rocchi M., van Oost B. A. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet. 1992 Oct;2(2):99–102. doi: 10.1038/ng1092-99. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES